KIAA1755 is a protein that, similar to the LOC nomenclature, has been identified through systematic sequencing of large genomic regions but has not been thoroughly characterized in terms of function. The "KIAA" prefix denotes that the protein was first identified in a large-scale cDNA sequencing project conducted by the Kazusa DNA Research Institute in Japan. The number "1755" serves as a unique identifier for this specific protein within the KIAA project database.The KIAA1755 protein is encoded by a gene that is predicted based on the sequence of cDNA clones. The gene's mRNA expression patterns, as well as the predicted amino acid sequence of the protein, may provide preliminary clues about its function. Often, KIAA proteins are of interest because they may represent novel proteins with potential roles in cellular biology that have not been previously described.
The study of KIAA1755 would include examining its sequence for recognizable motifs, domains, or signatures that could suggest a biological function. For example, a DNA binding domain might imply a role in transcriptional regulation, while a kinase domain might suggest involvement in signal transduction pathways.Bioinformatics tools can be used to predict subcellular localization, post-translational modifications, and potential interaction partners for KIAA1755. Experimental approaches, such as gene knockdown or overexpression studies, protein interaction assays, and localization studies, are essential to confirm these predictions and determine the physiological role of KIAA1755.
Items 1 to 10 of 11 total
展示:
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
SERCA 泵抑制剂会导致细胞膜钙水平升高,从而可能通过钙相关信号途径影响 EFCAB14/KIAA1755。 | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
增加细胞内钙水平的离子源,可能会通过改变钙依赖性信号通路影响 EFCAB14/KIAA1755 的活性。 | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
调节细胞内钙的释放,可能通过钙信号转导影响 EFCAB14/KIAA1755 的活性。 | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
增加细胞内钙水平,可能通过钙依赖信号影响 EFCAB14/KIAA1755 的活性。 | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $449.00 | 61 | |
细胞内钙螯合剂可通过调节钙信号转导间接影响 EFCAB14/KIAA1755 的活性。 | ||||||
EGTA | 67-42-5 | sc-3593 sc-3593A sc-3593B sc-3593C sc-3593D | 1 g 10 g 100 g 250 g 1 kg | $20.00 $62.00 $116.00 $246.00 $799.00 | 23 | |
用于研究细胞外钙作用的钙螯合剂可间接影响 EFCAB14/KIAA1755。 | ||||||
Nimodipine | 66085-59-4 | sc-201464 sc-201464A | 100 mg 1 g | $60.00 $301.00 | 2 | |
钙通道阻滞剂,主要是 L 型,可能通过改变钙离子流入影响 EFCAB14/KIAA1755 的活性。 | ||||||
Verapamil | 52-53-9 | sc-507373 | 1 g | $367.00 | ||
另一种钙通道阻滞剂,影响钙离子流入,可能影响 EFCAB14/KIAA1755 的活性。 | ||||||
Ryanodine | 15662-33-6 | sc-201523 sc-201523A | 1 mg 5 mg | $219.00 $765.00 | 19 | |
调节肌浆/内质网的钙释放,可能影响 EFCAB14/KIAA1755 的活性。 | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $101.00 $155.00 $389.00 $643.00 | 2 | |
储存操作钙离子进入的抑制剂,可能影响 EFCAB14/KIAA1755 的活性。 |